V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250012104 | 250011011 | 1.76 | 85 | null | 2015-06-23 | 2015-06-23 | Nilotinib | N | N | 250032817 | CARBOPLATIN + PACLITAXEL |
| 250012105 | 250012880 | 1.77 | 88.3 | Disease modification (D) | 2013-08-04 | 2013-08-15 | IPM | N | N | 250032838 | PACLITAXEL |
| 250012107 | 250008074 | null | 49.2 | Palliative (P) | 2014-08-19 | 2014-09-07 | Oxaliplatin + Raltitrexed | 02 | null | 250032919 | METHOTREXATE INTRATHECAL |
| 250012108 | 250011015 | 1.64 | null | Curative (C) | null | 2019-04-16 | Pemetrexed | N | null | 250032923 | GEMCITABINE |
| 250012109 | 250008078 | 0 | 69.2 | Disease modification (D) | 2013-12-10 | 2013-12-24 | IMATINIB | 2 | N | 250032944 | GEMCARBO |
| 250012110 | 250008081 | 1.61 | 68.2 | null | 2016-05-08 | 2016-05-08 | Rituximab (Maintenance) | 02 | N | 250032960 | GEMCARBO |
| 250012111 | 250008083 | 1.61 | 68.6 | Disease modification (D) | 2018-09-05 | 2018-09-08 | GemCarbo Days 1+8 | N | N | 250032971 | TEMOZOLOMIDE |
| 250012113 | 250008088 | null | null | Palliative (P) | 2015-07-17 | 2015-07-17 | IPM | 2 | N | 250033022 | GEMCARBO |
| 250012114 | 250008090 | 1.52 | 67.7 | Palliative (P) | 2015-07-02 | 2015-07-08 | CARBOPLATIN + PACLITAXEL | 2 | N | 250033023 | GEMCARBO |
| 250012115 | 250011020 | null | 59.8 | Disease modification (D) | 2014-04-14 | 2014-04-14 | Capecitabine | N | N | 250033031 | NOT MATCHED |
| 250012116 | 250008094 | 1.72 | 70 | null | 2016-07-11 | 2016-07-11 | GemCarbo Days 1+8 | N | N | 250033054 | GEMCARBO |
| 250012117 | 250011023 | 1.63 | 0 | Disease modification (D) | 2016-01-27 | 2016-01-27 | DACTINOMYCIN | 2 | N | 250033057 | COPP + DACARBAZINE |
| 250012118 | 250008100 | 1.7 | 94.8 | Disease modification (D) | 2016-11-03 | 2016-11-03 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | 02 | N | 250033067 | GEMCARBO |
| 250012119 | 250008106 | 1.7 | null | Palliative (P) | 2014-03-12 | 2014-04-23 | Cytarabine Low Dose | N | null | 250033098 | TEMOZOLOMIDE |
| 250012120 | 250008111 | 1.52 | 68 | Palliative (P) | null | 2014-09-30 | THALIDOMIDE | N | N | 250033113 | CHOP R |
| 250012121 | 250008113 | 1.57 | 92.1 | Disease modification (D) | 2017-07-10 | 2017-10-14 | IPM | N | N | 250000299 | GEMCARBO |
| 250012122 | 250008116 | 1.72 | 61.2 | Palliative (P) | 2017-07-09 | 2017-07-16 | COMMAND trial | 2 | N | 250000923 | COMMAND TRIAL |
| 250012123 | 250008122 | null | 63.4 | null | 2017-06-16 | 2018-02-05 | Carboplatin AUC 2 - 5 | 02 | null | 250001462 | DA |
| 250012124 | 250008125 | 0 | 60.8 | Palliative (P) | 2019-05-14 | 2019-05-21 | Carboplatin + Paclitaxel (weekly) | N | N | 250001559 | ERIBULIN |
| 250012125 | 250008127 | 1.8 | 81.8 | Curative (C) | 2017-11-18 | 2017-12-16 | IPM | N | N | 250001797 | CARBOPLATIN + VINORELBINE |
| 250012126 | 250008130 | null | 48.5 | Not known (9) | 2018-12-03 | 2018-12-17 | Busulfan Oral | 02 | N | 250002469 | CARBOPLATIN |
| 250012127 | 250008133 | 1.8 | 77 | Not known (9) | 2016-03-26 | 2016-04-16 | AML17 TRIAL | 02 | N | 250002533 | IPM |
| 250012128 | 250008136 | null | 48.7 | Palliative (P) | 2015-03-30 | 2015-04-02 | Y-90 | N | null | 250002579 | CARBOPLATIN + VINORELBINE |
| 250012129 | 250012619 | 1.58 | 54.799 | Palliative (P) | 2019-03-03 | 2019-03-03 | Brentuximab | 2 | N | 250002792 | GEMCARBO |
| 250012130 | 250008138 | null | 73 | Not known (9) | 2016-12-14 | 2016-12-14 | CYTARABINE | 02 | N | 250003100 | CAPECITABINE + GEMCITABINE |
| 250012131 | 250008138 | 1.72 | 49.7 | Palliative (P) | 2016-10-06 | 2016-10-06 | Pemetrexed | 02 | N | 250003100 | GEMCARBO |
| 250012132 | 250008140 | null | null | Curative (C) | 2017-03-23 | 2017-04-10 | GemCarbo Days 1+8 | N | null | 250003443 | FLAG + IDARUBICIN |
| 250012133 | 250008142 | 1.72 | 67 | Curative (C) | 2016-12-04 | 2018-08-10 | CARBOPLATIN + GEMCITABINE | 02 | N | 250003557 | DA |
| 250012134 | 250011034 | 1.61 | 72 | Palliative (P) | 2018-03-31 | 2018-10-28 | IPM | N | N | 250004027 | CHLORAMBUCIL + OFATUMUMAB |
| 250012135 | 250008145 | 1.53 | null | Curative (C) | 2018-11-20 | 2018-11-20 | CARBOPLATIN | 02 | null | 250004229 | BEVACIZUMAB |
| 250012136 | 250008146 | 1.64 | 88.3 | Curative (C) | 2017-01-20 | 2017-01-20 | CISPLATIN + VINORELBINE | 2 | N | 250004352 | IPM |
| 250012137 | 250008149 | null | 51.8 | Palliative (P) | 2019-10-22 | 2019-10-28 | Carboplatin + Liposomal Doxorubicin | N | N | 250004861 | COMMAND TRIAL |
| 250012138 | 250008150 | 1.91 | 60.5 | Disease modification (D) | 2017-07-24 | 2017-08-06 | ANAGRELIDE | 02 | Y | 250005040 | ESHAP R |
| 250012139 | 250008152 | null | 78.3 | Palliative (P) | 2014-02-08 | 2015-01-05 | BUSULFAN | N | N | 250005122 | NIVOLUMAB |
| 250012140 | 250008156 | null | null | Curative (C) | 2017-11-10 | 2018-02-08 | Alemtuzumab(INTRAVENOUS) | N | N | 250005192 | COMMAND TRIAL |
| 250012141 | 250008159 | 1.7 | 64.5 | Palliative (P) | 2016-11-15 | 2016-11-21 | GEMCARBO | N | N | 250005580 | IPM |
| 250012142 | 250008161 | null | 38.3 | Palliative (P) | 2018-04-26 | 2018-04-30 | IMATINIB | null | null | 250005596 | PACLITAXEL |
| 250012143 | 250008164 | 1.65 | 143 | Disease modification (D) | 2017-05-10 | 2017-12-15 | Carboplatin + Paclitaxel (weekly) | null | N | 250005674 | GEMCARBO |
| 250012144 | 250012179 | null | 52.6 | Palliative (P) | 2017-07-21 | 2017-07-30 | IPM | N | N | 250006185 | GEMCARBO |
| 250012145 | 250008167 | 1.55 | 0 | Curative (C) | 2016-03-01 | 2016-03-01 | Carboplatin + Etoposide IV 3 day | 02 | N | 250006185 | CHOP R |
| 250012146 | 250011046 | 1.72 | 74 | Palliative (P) | 2018-01-30 | 2018-07-08 | IPM | N | N | 250007030 | NIVOLUMAB |
| 250012147 | 250008172 | 1.55 | null | Disease modification (D) | 2015-07-29 | 2015-08-11 | TRASTUZUMAB EMTANSINE | 2 | N | 250007291 | CARBOPLATIN + VINORELBINE |
| 250012148 | 250012182 | 1.54 | 62.4 | Palliative (P) | 2014-11-11 | 2014-11-11 | Cisplatin | 2 | N | 250007319 | IPM |
| 250012149 | 250008177 | null | 82 | Disease modification (D) | 2017-08-09 | 2017-08-09 | INTERFERON | N | null | 250007949 | GEMCARBO |
| 250012150 | 250008179 | 1.64 | 97.6 | Curative (C) | 2015-06-25 | 2015-07-04 | Cisplatin | 2 | N | 250008267 | IPM |
| 250012151 | 250008180 | 1.73 | 0 | Curative (C) | null | 2019-06-18 | COMMAND trial | N | Y | 250008446 | AFLIBERCEPT + FU + IRINOTECAN |
| 250012152 | 250008182 | null | null | Palliative (P) | 2016-12-19 | 2018-03-16 | DOCETAXEL + GEMCITABINE | 02 | null | 250008458 | AZACITIDINE |
| 250012153 | 250008185 | 1.76 | 71.1 | Palliative (P) | 2019-06-01 | 2019-06-01 | null | N | null | 250008692 | GEMCARBO |
| 250012154 | 250011053 | 1.7 | 89.2 | Palliative (P) | null | 2018-01-30 | ATG + Busulfan + Fludarabine | N | N | 250008903 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250012155 | 250012808 | 1.78 | 49 | Disease modification (D) | 2014-08-06 | 2014-08-07 | Bortezomib +/- Dexamethasone | 2 | N | 250008946 | IPM |